Brean Capital initiates coverage on Covidien Ltd (NYSE: COV) with a Buy. PT $66.00.

The firm comments, "COV is ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE